Aktionärsstruktur der AstraZeneca PLC
Portrait der AstraZeneca Aktie
Das Unternehmen AstraZeneca PLC aus Großbritannien ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Biotechnologie & Pharmazeutika, Pharma tätig.
ASTRAZENECA PHARMA INDIA LTD ist ein Tochterunternehmen von AstraZeneca.
Das Unternehmen AstraZeneca PLC ist in mehr als 74 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe 600 Health Care UCITS ETF (DE) gewichtet AstraZeneca mit 9,81% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle AstraZeneca Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen AstraZeneca PLC am höchsten gewichtet ist Insgesamt in 74 ETFs enthalten
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
633 News & Informationen zur AstraZeneca Aktie
COVID vaccine protection wanes within six months
COVID vaccine protection wanes within six months – UK researchers
U.S. Stocks May Show A Lack Of Direction In Early Trading
(RTTNews) – The major U.S. index futures are currently pointing to a roughly flat open on Wednesday, with stocks likely to show a lack of directio…
Silence Therapeutics to Participate in September Investor Conferences
Silence Therapeutics to Participate in September Investor Conferences 25 August 2021 LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq: SLN…
Taiwan to get BioNTech shots early as China delays approval-source
TAIPEI — Taiwan could get its first delivery of BioNTech SE’s COVID-19 vaccines one month ahead of schedule as a delay in regulatory approval of the shot for…
Cerebras Systems connects its huge chips to make AI more power-efficient
Cerebras Systems, the Silicon Valley startup making the world’s largest computer chip, said on Tuesday it can now weave together almost 200 of the chips to…
PFM Health Sciences, LP Buys Seagen Inc, Centene Corp, ACADIA Pharmaceuticals Inc, Sells PPD Inc, Jaws Acquisition Corp, Insulet Corp
GuruFocus Article or News written by insider and the topic is about:
5 Best Dividend Stocks to Buy Now
There’s enough for investors to worry about. But there are ways to have peace of mind when it comes to your portfolio. And these dividend stocks are just the thing…
Global Microbiome Market Marching Towards The Mainstream
DUBLIN, Aug. 24, 2021 /PRNewswire/ — The
Global Microbiome Market Marching Towards the Mainstream
/PRNewswire/ — The
The Family Office Saving Lives, Boosting The Economy And Making Billions
In a small Family Office in Munich sit two brothers who have helped saved millions of lives, boosted Germany’s economy and enabled nations, across the world, to re-open in the middle of a pandemic.
Why AstraZeneca Stock Is A Buy For Dividend-Income Investors (NASDAQ:AZN)
AstraZeneca has a better growth score than peers because of its conservative allocation policies. Here’s why I believe that Market is ignoring AZN’s double-digit percentage growth.
Stocks and commodities cling to gains
Markets in Europe and Asia continue to recover from last week’s sharp declines
Rock Springs Capital Management LP Buys Agilon Health Inc, Immunocore Holdings PLC, Graphite Bio Inc, Sells , Atea Pharmaceuticals Inc, AstraZeneca PLC
GuruFocus Article or News written by insider and the topic is about:
Davidson Kempner Capital Management LP Buys , Willis Towers Watson PLC, , Sells , Qiagen NV, RealPage Inc
GuruFocus Article or News written by insider and the topic is about:
India’s vaccination drive against covid-19 crosses 582.5 million doses
According to a statement from India’s ministry of health and family welfare on Monday, the recovery rate was at 97.63%, the highest since March 2020
JD.com Announces 2021 Second Quarter and Interim Results
BEIJING, China, Aug. 23, 2021 (GLOBE NEWSWIRE) — JD.com, Inc. (NASDAQ: JD and HKEX: 9618), a leading supply chain-based technology and service provider,…
Taiwan's president leads way in first domestic COVID-19 vaccine By Reuters
Taiwan's president leads way in first domestic COVID-19 vaccine
Taiwan rolls out first homegrown Covid-19 shots to bypass vaccine woes
President Tsai Ing-wen will be among the first on Monday to get the vaccine developed by Taipei-based Medigen Vaccine Biologics Corporation
Australia’s PM Morrison defends lockdown strategy until majority vaccinated
MELBOURNE: Australia’s Prime Minister Scott Morrison (pix) today defended the country’s lockdown strategy to combat coronavirus outbreaks until at lea…
World may never reach herd immunity against Covid-19
As Covid-19 surged last year, governments worldwide touted the hope of “herd immunity,” a promised land where the virus stopped spreading exponentially because enough people were protected against it. That’s now looking like a fantasy. The thinking was that the pandemic would ebb and then mostly fade once a chunk…
India Approves DNA-based Covid Shot, Boosting Vaccine Plan
(Bloomberg) — India granted emergency-use approval to its first DNA-based vaccine against Covid-19 as the world’s second-worst-hit nation seeks to bolster its immunization drive to ward off a possible third wave of infections.
Covid, China worries and Fed keep shares in check
Recap: Global shares fell for the fifth straight day yesterday as investors fretted about the spread of the Delta coronavirus variant, slowing Chinese growth and the timing of Federal Reserve stimulus reduction. The US dollar continued to rise as a safe haven after hitting nine-month high on Thursday.
As Covid-19 Boosters Loom, Pfizer and Moderna Expect to See Billions More in Sales
Vaccine makers Pfizer Inc. and Moderna Inc. are on track to notch billions more in sales than previously expected, as new booster-shot strategies and concerns about the Delta variant push demand, and the companies raise prices in the U.S. and elsewhere.
AstraZeneca (AZN) Stops Phase III Study on Ultomiris for ALS
AstraZeneca (AZN) stops the phase III CHAMPION-ALS study on Ultomiris for treating adults with amyotrophic lateral sclerosis, following a recommendation from the Independent Data Monitoring Committee.
Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
SAN FRANCISCO, Aug. 20, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research comp…
Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
AstraZeneca's antibody therapy prevents COVID-19, study shows By Reuters
AstraZeneca's antibody therapy prevents COVID-19, study shows
Coronavirus tally: U.S. daily average of COVID-19 cases, deaths and hospitalization rise to multi-month highs
The global tally for the coronavirus-borne illness climbed above 210 million as of early Friday, while death toll rose to 4,404,511, according to data…
AstraZeneca : Update on CHAMPION-ALS Phase III trial of Ultomiris in amyotrophic lateral sclerosis (Form 6-K)
Update on CHAMPION-ALS Phase III trial of Ultomiris in amyotrophic lateral sclerosis
Alexion is discontinuing CHAMPION-ALS, the global Phase III clinical trial of Ultomiris in… | August 20, 2021
AstraZeneca : AZD7442 PROVENT Phase III prophylaxis trial met primary endpoint in preventing COVID-19 (Form 6-K)
derived from B-cells donated by convalescent patients after SARS-CoV-2 virus. Discovered by Vanderbilt University Medical Center and licensed to AstraZeneca in June 2020, the human monoclonal… | August 20, 2021
AstraZeneca Antibody Drug Found to Prevent Symptomatic Covid-19 in Trial
The company said it would seek regulatory approval after a study showed strong efficacy in preventing symptomatic Covid-19, offering a potential alternative to vaccines for people who refuse shots or for whom they aren’t effective.
AstraZeneca: Alexion To Discontinue CHAMPION-ALS Phase 3 Trial Of Ultomiris In ALS
(RTTNews) – British drug major AstraZeneca (AZN.L, AZN) Friday announced that its unit focused on rare diseases, Alexion Pharmaceuticals, Inc., is…
Indian States preparing for next Covid wave focus on children
Have taken heed of trends in the US where a record number of children have been hospitalised due to the Delta variant
Meyer Handelman Co Buys Travel+Leisure Co, TJX Inc, Salesforce.com Inc, Sells Travel+Leisure Co, Viatris Inc,
GuruFocus Article or News written by insider and the topic is about:
Pascal Soriot, chief executive officer of Astrazeneca Plc
Global Intranasal Drug Delivery Market Forecast to 2027: Burgeoning Geriatric Populace Spurs Growing Demand
/PRNewswire/ — The
Global Intranasal Drug Delivery Market Forecast To 2027: Burgeoning Geriatric Populace Spurs Growing Demand
DUBLIN, Aug. 19, 2021 /PRNewswire/ — The
Concerns About Tapering Likely To Lead To Continued Weakness On Wall Street
The major U.S. index futures are currently pointing to a sharply lower open on Thursday, with stocks likely to extend the pullback seen over the two previous sessions.
Australia new cases hit record; jabs less effective against Delta
Australia suffered its worst day since the start of the Covid-19 pandemic, with cases surpassing the record posted more than a year ago as an outbreak of the Delta variant spreads. New South Wales recorded 681 new cases, Premier Gladys Berejiklian told reporters on Thursday in Sydney, where stay-at-home orders…
As covid-19 boosters loom, Pfizer and Moderna expected to see billions more in sales
The spread of the Delta variant is increasing demand for messenger RNA vaccines and boosters, while the companies raise prices